← 返回首页
美国 · 财经报刊 · Investor's Business Daily

Dow Jones Biotech Giant Amgen In Buy Zone Amid Ongoing Stock Market Weakness

来源:Investor's Business Daily · 美国 57 分钟前
Dow Jones Biotech Giant Amgen In Buy Zone Amid Ongoing Stock Market Weakness
Investor's Business Daily

详细摘要

Dow Jones biotech giant Amgen stock is trading in a buy zone following its recent breakout move amid the ongoing market weakness. The post Dow Jones Biotech Giant Amgen In Buy…

Dow Jones biotech giant Amgen (AMGN) is at the top of its buy zone following a recent breakout move, making it Monday's IBD 50 Growth Stocks To Watch pick. Last week, Amgen unveiled positive test results for one of the first immune-modulating treatments for Sjogren's disease. In Sjogren's disease, the immune system mistakenly attacks the body's moisture-producing glands. This can…

文章开头,摘自Investor's Business Daily。如需阅读全文,请前往媒体网站。

在 Investor's Business Daily 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.investors.com)

推荐阅读